Compugen Ltd. CGEN

NAS: CGEN | ISIN: IL0010852080 7/08/2026

2,410 USD (+4,78%)

(+4,78%) 7/08/2026

Grafiek Compugen Ltd.

Grafiek Compugen Ltd.

1 dag1d 4,78%
1 week1w 1,26%
1 maand1m 0,84%
3 maanden3m -16,03%
6 maanden6m 36,93%
1 jaar1j 60,67%
5 jaar5j -63,54%

Compugen Ltd. in het nieuws

Toon enkel gratis nieuws

3 augustus 2026 · Compugen Reports Second Quarter 2026 Results · Persbericht

21 juli 2026 · Compugen to Participate in BTIG Biotechnology Conference 2026 · Persbericht

20 juli 2026 · Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026 · Persbericht

18 juni 2026 · Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress · Persbericht

11 juni 2026 · Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 · Persbericht

8 juni 2026 · Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development · Persbericht

18 mei 2026 · Compugen Reports First Quarter 2026 Results · Persbericht

12 mei 2026 · Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum · Persbericht

4 mei 2026 · Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 · Persbericht

9 april 2026 · Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference · Persbericht

Profiel Compugen Ltd.

Gezondheidstechnologie

Website: www.cgen.com

Hoofdzetel: Holon Israël

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe